Endonovo Therapeutics, Inc.
ENDV · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $2 | $0 | $86 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $18 | $18 | $16 | $8 |
| Total Curr. Assets | $18 | $20 | $16 | $95 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $619 | $1,265 | $1,912 |
| Long-Term Investments | $2 | $2 | $2 | $2 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | -$2 | -$2 |
| Total NC Assets | $2 | $620 | $1,265 | $1,912 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $19 | $640 | $1,281 | $2,007 |
| Liabilities | – | – | – | – |
| Payables | $3,427 | $1,080 | $882 | $658 |
| Short-Term Debt | $6,870 | $7,073 | $7,153 | $7,181 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $6,420 |
| Other Curr. Liab. | $16,445 | $16,514 | $25,347 | $3,442 |
| Total Curr. Liab. | $26,742 | $24,666 | $33,382 | $17,702 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $80 | $80 | $80 | $80 |
| Total NC Liab. | $80 | $80 | $80 | $80 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $26,822 | $24,746 | $33,462 | $17,782 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $54 | $33 | $21 | $7 |
| Retained Earnings | -$71,031 | -$68,234 | -$75,119 | -$56,443 |
| AOCI | $0 | -$33 | -$2 | -$2 |
| Other Equity | $44,174 | $44,128 | $42,919 | $40,663 |
| Total Equity | -$26,803 | -$24,106 | -$32,180 | -$15,774 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $19 | $640 | $1,281 | $2,007 |
| Net Debt | $6,870 | $7,071 | $7,153 | $7,095 |